Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.070
0.00 (0.00%)
Mar 10, 2026, 1:49 PM EDT - Market open
Stereotaxis Revenue
In the year 2025, Stereotaxis had annual revenue of $32.38M with 20.28% growth. Stereotaxis had revenue of $8.64M in the quarter ending December 31, 2025, with 36.31% growth.
Revenue (ttm)
$32.38M
Revenue Growth
+20.28%
P/S Ratio
6.89
Revenue / Employee
$216,367
Employees
139
Market Cap
193.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.38M | 5.46M | 20.28% |
| Dec 31, 2024 | 26.92M | 147.00K | 0.55% |
| Dec 31, 2023 | 26.77M | -1.38M | -4.89% |
| Dec 31, 2022 | 28.15M | -6.87M | -19.63% |
| Dec 31, 2021 | 35.02M | 8.39M | 31.51% |
| Dec 31, 2020 | 26.63M | -2.27M | -7.86% |
| Dec 31, 2019 | 28.90M | -444.07K | -1.51% |
| Dec 31, 2018 | 29.35M | -1.80M | -5.77% |
| Dec 31, 2017 | 31.14M | -1.02M | -3.17% |
| Dec 31, 2016 | 32.16M | -5.51M | -14.63% |
| Dec 31, 2015 | 37.67M | 2.66M | 7.61% |
| Dec 31, 2014 | 35.01M | -3.02M | -7.94% |
| Dec 31, 2013 | 38.03M | -8.53M | -18.32% |
| Dec 31, 2012 | 46.56M | 4.58M | 10.90% |
| Dec 31, 2011 | 41.99M | -12.06M | -22.32% |
| Dec 31, 2010 | 54.05M | 2.90M | 5.67% |
| Dec 31, 2009 | 51.15M | 10.78M | 26.72% |
| Dec 31, 2008 | 40.37M | 1.07M | 2.71% |
| Dec 31, 2007 | 39.30M | 12.11M | 44.52% |
| Dec 31, 2006 | 27.19M | 12.17M | 80.96% |
| Dec 31, 2005 | 15.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Embecta | 1.08B |
| AngioDynamics | 307.31M |
| OraSure Technologies | 115.02M |
| Sanara MedTech | 101.88M |
| Pro-Dex | 72.10M |
| KORU Medical Systems | 39.07M |
| Utah Medical Products | 38.52M |
| Nyxoah | 6.62M |
STXS News
- 17 hours ago - Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 hours ago - Stereotaxis Reports 2025 Full Year Financial Results - GlobeNewsWire
- 26 days ago - Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026 - GlobeNewsWire
- 4 weeks ago - Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program - GlobeNewsWire
- 2 months ago - Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter - GlobeNewsWire
- 3 months ago - Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - Stereotaxis, Inc. (STXS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Stereotaxis Reports 2025 Third Quarter Financial Results - GlobeNewsWire